Sky Century Investment (SKYI) Free Cash Flow (2012 - 2026)
Sky Century Investment (SKYI) posted quarterly Free Cash Flow of -$59238.0 for Q2 2026, down 246.41% year-over-year from $40460.0 in Q2 2025, and down 2813.61% quarter-over-quarter from $2183.0 in Q1 2026.
Sky Century Investment (SKYI) Free Cash Flow (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Free Cash Flow for 6 consecutive years, with -$59238.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Free Cash Flow fell 246.41% year-over-year to -$59238.0; the TTM figure through May 2026 stood at -$37040.0 (down 202.19% YoY), while the FY2025 annual figure was $30941.0, up 6275.85% from the prior year.
- Free Cash Flow retreated to -$59238.0 in Q2 2026 per SKYI's latest filing, from $2183.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $40460.0 in Q2 2025 and bottomed at -$59238.0 in Q2 2026.
- Historically, Free Cash Flow has averaged -$1728.5 across 3 years, with a median of -$6051.5 in 2024.
- Annual changes were most pronounced in 2025 — Free Cash Flow soared 786.58% — and 2026, when it tumbled 246.41%.
- Sky Century Investment's Free Cash Flow stood at -$10827.0 in 2024, then surged by 42.64% to -$6210.0 in 2025, then slumped by 853.91% to -$59238.0 in 2026.
- Business Quant data shows SKYI's Free Cash Flow at -$59238.0 in Q2 2026, $2183.0 in Q1 2026, and -$6210.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -59,238.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -59,238.00 |
| May 31, 2026 | -59,238.00 |
| Feb 28, 2026 | 2,183.00 |
| Feb 28, 2026 | 2,183.00 |
| Nov 30, 2025 | -6,210.00 |
| Nov 30, 2025 | -6,210.00 |
| Aug 31, 2025 | 26,225.00 |
| Aug 31, 2025 | 26,225.00 |
| May 31, 2025 | 40,460.00 |
| May 31, 2025 | 40,460.00 |
| Feb 28, 2025 | -9,377.00 |
| Feb 28, 2025 | -9,377.00 |
| Nov 30, 2024 | -10,827.00 |
| Nov 30, 2024 | -10,827.00 |
| Aug 31, 2024 | 15,990.00 |
| Aug 31, 2024 | 15,990.00 |
| May 31, 2024 | -5,893.00 |
| May 31, 2024 | -5,893.00 |
| Feb 29, 2024 | -10,598.00 |
| Feb 29, 2024 | -10,598.00 |